Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
08/2000
08/09/2000EP1024821A1 Novel prokaryotic polynucleotides, polypeptides and their uses
08/09/2000EP1024820A1 Androgen activity antagonists as therapies for anorexia, anorexia nervosa, and disorders characterized by a pathologically underweight condition
08/09/2000EP1024815A1 Pharmaceutical compositions for oral administration of molecular iodine
08/09/2000EP1024814A2 Use of antifungal agents for the topical treatment of fungus-induced mucositis
08/09/2000EP1024812A1 Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
08/09/2000EP1024810A1 Method for optimizing retinal and optic nerve health
08/09/2000EP1024809A1 Use of immunomodulating agents
08/09/2000EP1024806A1 Use of non-immunosuppressive compounds for promoting nerve regeneration
08/09/2000EP1024804A1 Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
08/09/2000EP1024803A1 Flavonoids for cystic fibrosis therapy
08/09/2000EP1024801A2 Method for regulating size and growth of vascularized normal tissue
08/09/2000EP1024799A1 Method for treating disease-related or drug-induced dyskinesias
08/09/2000EP1024798A1 Neomycin/disaccharide water solution for enteroclysis in hepatic encephalopathy
08/09/2000EP1024792A1 Topical antifungal composition
08/09/2000EP1024697A1 Method for treating alzheimer's disease
08/09/2000EP1024696A1 Combination therapy for reducing the risks associated with cardio- and cerebrovascular disease
08/09/2000EP0786083B1 Diagnosis and monitoring process, and medicaments for the therapy of states of shock in human beings
08/09/2000EP0732915B1 Local delivery of fibrinolysis enhancing agents
08/09/2000CN1262675A (+)-Norcisapride useful for 5-HT3 and 5-HT4 mediated disorbers
08/09/2000CN1262627A Composition
08/09/2000CN1262625A Use of lactoferin in treatment of allergen induced disorders
08/09/2000CN1262622A Combination therapy for modulating human sexual response
08/09/2000CN1262616A Topical application of combination of benzoyl peroxide and second active ingredient
08/09/2000CN1262600A Compositions and method for reducing respiratory depression and attendant side effects of mu opioid compounds
08/08/2000US6101412 Compositions, apparatus and methods for facilitating surgical procedures
08/08/2000US6100286 Methods and formulations for modulating the human sexual response
08/08/2000US6100279 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
08/08/2000US6100277 Retroviral protease inhibitor combinations
08/08/2000US6100249 Use of aspirin for the manufacture of a medicament for implanting an embryo into the uterine endometrium
08/08/2000US6100243 Method of sensitizing tumor cells with adenovirus E1A
08/08/2000US6100234 Treatment of HIV
08/08/2000US6100060 Recombinant expression system of polynucleotide encoding a specific amino acid sequence and present in a host cell; for recombinant production of wnt-5b polypeptides important in developmental signal transduction
08/08/2000US6100048 Using a panel of mammalian cells transformed with recombinant expression constructs encoding a variety of melanocortin receptors; contacting cells with compound, detecting binding, and determing if compound inhibits feeding behavior
08/08/2000US6100037 Polynucleotide encoding a cyclic nucleotide phosphodiesterase having a specific amino acid sequence; diagnosis, treatment, and prevention of cancer and immune disorders; anticarcinogenic/antidiabetic/antiarthritic agents
08/08/2000US6099854 Dry composition containing flavonol useful as a food supplement
08/08/2000US6099841 Include hgf receptor antibodies and fragments thereof; used to treat a pathological liver condition
08/08/2000US6099838 For the prevention or reversal of transplant rejection as well as therapy for autoimmune diseases
08/08/2000US6099837 Pharmaceutical preparation for treating blood coagulation disorders
08/08/2000US6099823 Compositions and methods for the treatment and diagnosis of cardiovascular disease
08/08/2000CA2188227C Combination antiemetic therapy using nk-1 receptor antagonists
08/08/2000CA2125904C Controlled release formulations coated with aqueous dispersions of ethylcellulose
08/08/2000CA2056653C Preparation for transdermal drug administration
08/08/2000CA1341082C Method of treating tumor cells by inhibiting growth factor receptor function
08/08/2000CA1341077C Luminide and macroluminide class of pharmaceuticals
08/03/2000WO2000044912A1 Manipulating isoprenoid expression
08/03/2000WO2000044903A1 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof
08/03/2000WO2000044901A1 Transcriptional regulation of the human beta3-adrenergic receptor gene
08/03/2000WO2000044888A2 Dimethylarginine dimethylaminohydrolases
08/03/2000WO2000044786A1 Novel potassium channels and genes encoding these potassium channels
08/03/2000WO2000044774A2 Inhibition of stat3 signal transduction for human cancer therapy
08/03/2000WO2000044763A2 Compositions for treating inflammatory response
08/03/2000WO2000044408A2 Method of treating demyelinating inflammatory disease using ccr1 antagonists
08/03/2000WO2000044404A2 Methods for inhibiting brain tumor growth by using selected integrin antagonists
08/03/2000WO2000044400A1 Treatment for diabetes
08/03/2000WO2000044399A2 Treatment of erectile dysfunctions with a c-type natriuretic polypeptide (cnp) as monotherapy or in combination with phosphodiesterase inhibitors
08/03/2000WO2000044398A2 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions
08/03/2000WO2000044382A1 Composition and method for treating diabetes
08/03/2000WO2000044379A2 Methods for restoring and/or enhancing accommodation in pseudo phakia
08/03/2000WO2000044378A1 Use of angiotensin ii receptor antagonists for treating acute myocardial infarction
08/03/2000WO2000044372A1 A method for treating patients with acne by administering a cyclic gmp pde inhibitor
08/03/2000WO2000044365A1 Methods for preventing graft rejection and ischemia-reperfusion injury
08/03/2000WO2000044364A2 P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant
08/03/2000WO2000044359A2 Utilisation of thiadizole derivatives for the prophylactic and therapeutic treatment of infections
08/03/2000WO2000044358A2 Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
08/03/2000WO2000044352A1 Method of preparing particles for agglomeration
08/03/2000WO2000044342A1 Galenic formulation containing biotin
08/03/2000WO2000044240A1 Treatement of colic and gut spasm in horses and other vertebrates
08/03/2000WO2000044225A1 TREATING CANCERS ASSOCIATED WITH OVEREXPRESSION OF HER-2/neu
08/03/2000WO2000032175A3 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
08/03/2000WO2000028947A3 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress
08/03/2000WO2000026238A3 Biological materials and methods useful in the diagnosis and treatment of prion diseases
08/03/2000WO2000023065A3 Storable active substance concentrate with formoterol
08/03/2000WO2000021926A3 6-SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS
08/03/2000WO2000021520A3 Opioid analgesic
08/03/2000WO2000012110A3 Use of anti(w)pressor agents for vascular remodeling in genital dysfunction
08/03/2000WO2000010533A9 Compositions and methods for treating intracellular infections
08/03/2000WO2000009550A9 Vanadate resistance glycosylation 4 gene
08/03/2000WO2000009549A9 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
08/03/2000WO2000009102A9 Carboxylic acids and isosteres of n-heterocyclic compounds for vision and memory disorders
08/03/2000WO1999063975A3 A method for stimulating the immune system
08/03/2000DE19903666A1 Arzneimittel mit einem Gehalt an 3-Isoxazolidinonen und Hydroxylaminsäuren als Wirkstoff und ihre Verwendung Drug with a content of 3-Isoxazolidinonen Hydroxylaminsäuren and as active ingredient and their use
08/03/2000DE19903241A1 Galenische Formulierung Drug formulation
08/03/2000DE19902924A1 Verwendung von phosphororganischen Verbindungen zur prophylaktischen und therapeutischen Behandlung von Infektionen Use of organophosphorus compounds in the prophylactic and therapeutic treatment of infections
08/03/2000CA2361621A1 Inhibition of stat3 signal transduction for human cancer therapy
08/03/2000CA2361614E Compositions for treating inflammatory response
08/03/2000CA2361260A1 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions
08/03/2000CA2361256A1 Method of treating demyelinating inflammatory disease using ccr1 antagonists
08/03/2000CA2361239A1 Treatment of erectile dysfunctions with a c-type natriuretic polypeptide (cnp) as monotherapy or in combination with phosphodiesterase inhibitors
08/03/2000CA2360691A1 Use of angiotensin ii receptor antagonists for treating acute myocardial infarction
08/03/2000CA2360687A1 Composition and method for treating diabetes
08/03/2000CA2360672A1 Methods for preventing graft rejection and ischemia-reperfusion injury
08/03/2000CA2360671A1 P53 inhibitors and therapeutic use of the same
08/03/2000CA2360661A1 Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
08/03/2000CA2360334A1 Manipulating isoprenoid expression
08/03/2000CA2360146A1 Methods for inhibiting brain tumor growth by using selected integrin antagonists
08/03/2000CA2360064A1 Transcriptional regulation of the human beta3-adrenergic receptor gene
08/03/2000CA2357525A1 Treating cancers associated with overexpression of her-2/neu
08/03/2000CA2326741A1 The use of gastrin in the treatment of diabetes
08/02/2000EP1023907A1 Medicinal compositions with cholesterol-lowering effect
08/02/2000EP1023906A1 Potentiator for antibody against lymphoid tumor
1 ... 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 ... 1151